Raymond Cheong
Director/Board Member at TALIS BIOMEDICAL CORPORATION
Net worth: - $ as of 30/03/2024
Profile
Dr. Raymond Cheong is on the Board of Directors at vTv Therapeutics, Inc., Madrigal Pharmaceuticals, Inc., Talis Biomedical Corp.
and Istari Oncology, Inc. Dr. Cheong also served on the board at Talis Biomedical Corp.
He received his undergraduate degree from the University of Maryland and a doctorate degree from The Johns Hopkins University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TALIS BIOMEDICAL CORP.
-.--% | 30/01/2024 | 0 ( -.--% ) | - $ | 30/03/2024 |
Raymond Cheong active positions
| Companies | Position | Start |
|---|---|---|
| TALIS BIOMEDICAL CORPORATION | Director/Board Member | 09/03/2023 |
| MADRIGAL PHARMACEUTICALS, INC. | Director/Board Member | 14/06/2023 |
| VTV THERAPEUTICS INC. | Director/Board Member | 26/02/2024 |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Director/Board Member | 30/11/2018 |
Former positions of Raymond Cheong
| Companies | Position | End |
|---|---|---|
| TALIS BIOMEDICAL CORPORATION | Director/Board Member | 09/06/2022 |
Training of Raymond Cheong
| The Johns Hopkins University | Doctorate Degree |
| University of Maryland | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| VTV THERAPEUTICS INC. | Health Technology |
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| TALIS BIOMEDICAL CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Health Technology |
- Stock Market
- Insiders
- Raymond Cheong
